Greenleaf Peter 4
4 · Pelthos Therapeutics Inc. · Filed Jul 7, 2025
Insider Transaction Report
Form 4
Greenleaf Peter
Director
Transactions
- Award
Restricted Stock Units
2025-07-02+25,478→ 25,478 totalExercise: $13.50From: 2026-07-02Exp: 2035-07-02→ Common Stock (25,478 underlying) - Award
Stock Option
2025-07-02+77,640→ 77,640 totalExercise: $13.50From: 2026-07-02Exp: 2035-07-02→ Common Stock (77,640 underlying)
Footnotes (2)
- [F1]On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 25,478 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2025, and in equal installments on a quarterly basis thereafter over a period of two (2) years.
- [F2]On July 2, 2025, the Reporting Person was granted stock options to purchase 77,640 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2025, and in equal installments on a quarterly basis thereafter over a period of two (2) years.